Follow The Filings

TAK

Earnings company data as of 3:58 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 0.31 — —
Rev — — —

Insider trades

Open-market buys and sales by TAK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TAK insider trades
  • None no insider bought on the open market
  • $1.8M sold by 3 insiders outside a trading plan
  • $2.5M sold by 1 insider under 10b5-1 plans
  1. Lauren Rusckowski Duprey Chief Transformation Officer
    Sale
    $640K 34,535 shares at $18.54 15% of stake
    Traded Sep 14 Filed Sep 15
    ↗
  2. Andrew Stewart Plump President, R&D
    Planned sale
    $2.1M 116,191 shares at $18.49 44% of stake
    Traded Sep 2 Filed Sep 3
    ↗
  3. Andrew Stewart Plump President, R&D
    Planned sale
    $363K 19,651 shares at $18.49 7% of stake
    Traded Aug 19 Filed Aug 21
    ↗
  4. Nicola Deidre Petal Greenway Chief Human Resources Officer
    Sale
    $235K 12,980 shares at $18.11 25% of stake
    Traded Aug 18 Filed Aug 19
    ↗
  5. Elaine Mary Shannon Pres., Global Supply & Quality
    Sale
    $357K 20,363 shares at $17.55 23% of stake
    Traded Aug 11 Filed Aug 12
    ↗
  6. Nicola Deidre Petal Greenway Chief Human Resources Officer
    Sale
    $606K 34,603 shares at $17.51 37% of stake
    Traded Aug 10 Filed Aug 12
    ↗

Also filed in the last 12 months, not counted as buying or selling: 35 stock grants and 13 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 6 shown.

Filed Form Detail Links
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc

Source: SEC EDGAR submissions, updated about 1 month ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.